ubmslateCN-logo-ubm

CN Mobile Logo

Search form

Topics:

All Content

Researchers evaluated cervical cancer screening rates in the severely mentally ill enrolled in California’s Medicaid program and noted lower than average rates in this population.

Trimodality therapy achieved improved locoregional control among a cohort of women with nonmetastatic inflammatory breast cancer.

Results of a new study suggest that breast cancer–related lymphedema is strongly associated with multimodality treatment, including chemotherapy, and not axillary node surgery alone.

The 2013 ASCO/CAP updates to HER2 testing guidelines did not result in changes to the rate of HER2 positivity among breast cancer patients.

The FDA has approved regorafenib (Stivarga) for the second-line treatment of hepatocellular carcinoma (HCC) for patients who have previously received sorafenib.

Women who undergo bilateral mastectomy for the treatment of DCIS may be overtreated, according to the results of a new study.

In this interview we discuss new clinical guidelines from ASTRO on the use of radiotherapy in treating oropharyngeal cancer.

The higher prostate cancer death rates seen among black men in the United States may be due to a higher incidence of preclinical disease and higher risk of metastatic progression, suggesting that different screening policies could benefit this population.

A 46-year-old man presents with hematuria, and a bladder biopsy is performed. What is your diagnosis?

A subset of patients with advanced renal cell carcinoma experienced a reduction in tumor size after undergoing postprogression treatment with nivolumab.

Pages

By clicking Accept, you agree to become a member of the UBM Medica Community.